Le Lézard
Classified in: Health
Subjects: CCA, SLS

Capio to Publish Interim Report on October 27, 2017



GOTHENBURG, Sweden, Oct. 6, 2017 /PRNewswire/ -- Capio AB will publish the interim report for January-September 2017 on Friday, October 27 at approximately 08.00 am (CET).

08.00 am (approximately)

Report release. The report will be sent as a press release and will be published on Capio's website www.capio.com.

09.30 am Telephone conference and audio cast

Investors, analysts and media are invited to participate in a telephone conference at 09.30 am (CET).

President and CEO Thomas Berglund and CFO Olof Bengtsson will present the report and answer questions (in English).

The telephone conference will be audio casted live on www.capio.com.

To participate in the telephone conference, please register at www.capio.com and dial in five minutes prior to the start of the conference call.

Sweden: +46-8-566-426-93 UK: +44-203-008-98-04 US: +1-855-753-22-37 Finland: +35-898-171-04-93 France: +33-170-75-07-12

Prior to the start of the telephone conference, presentation slides will be available at www.capio.com.

A recorded version of the audio cast will be made available at

www.capio.com

during the afternoon (CET).

Subscribe to press releases and financial information

To receive press releases and financial reports from Capio, please subscribe at www.capio.com/subscribe.

For information, please contact:
Olof Bengtsson
CFO
Telephone: +46-761-18-74-69

Kristina Ekeblad
IR manager
Telephone: +46-708-31-19-40

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/capio-ab/r/capio-to-publish-interim-report-on-october-27--2017,c2361694

The following files are available for download:

http://mb.cision.com/Main/277/2361694/732442.pdf

PDF


These press releases may also interest you

at 02:29
Camurus announced today that the US Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of December 26, 2018 for its investigational weekly and monthly buprenorphine depots, CAM2038, for the treatment of...

at 02:00
FARO® , the world's most trusted source for 3D measurement and imaging solutions for factory metrology, construction BIM, product design, public safety forensics, and 3D machine vision applications announces the acquisition of Opto-Tech s.r.l. and...

at 02:00
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, in collaboration with Diazyme Laboratories, Inc. is offering three new Microtip Partnership Assays to their customers. The Microtip Partnership Assay (MPA) program enables...

at 01:03
NewStem Ltd., a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness, today announced a $4 million seed financing from a publicly-traded US-based company to be named NovelStem International...

at 01:00
HOWELL, Mich., July 16, 2018 /PRNewswire-PRWeb/ -- Podiatrist Dr. Tom Biernacki was recently awarded an outstanding achievement award for the excellent care he has provided for the St. Joseph Mercy Hospital system in the Brighton location and the...

at 01:00
DANBURY, Conn., July 16, 2018 /PRNewswire-PRWeb/ -- To further its support of cities which have suffered tremendously from the destructive effects of the opioid epidemic, the Firm has agreed to donate $20,000 to the Western Connecticut Health Network...




News published on 6 october 2017 at 03:32 and distributed by: